Oxford Endovascular Ltd. Revenue and Competitors
Estimated Revenue & Valuation
- Oxford Endovascular Ltd.'s estimated annual revenue is currently $2.3M per year.
- Oxford Endovascular Ltd.'s estimated revenue per employee is $230,400
Employee Data
- Oxford Endovascular Ltd. has 10 Employees.
- Oxford Endovascular Ltd. grew their employee count by -9% last year.
Oxford Endovascular Ltd.'s People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP Regulatory Affairs and Quality Assurance | Reveal Email/Phone |
3 | Director Research and Development | Reveal Email/Phone |
4 | Senior Design Assurance Engineer | Reveal Email/Phone |
5 | Senior Research and Development Engineer | Reveal Email/Phone |
6 | Chairman | Reveal Email/Phone |
Oxford Endovascular Ltd. Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2.7M | 12 | 20% | N/A | N/A |
#2 | $75M | 2059 | N/A | N/A | N/A |
#3 | $1.1M | 6 | 200% | N/A | N/A |
#4 | $0.3M | 2 | 0% | N/A | N/A |
#5 | $16.7M | 49 | 7% | $14.8M | N/A |
#6 | $2.3M | 10 | 67% | N/A | N/A |
#7 | $211.2M | 444 | -1% | N/A | N/A |
#8 | $5.4M | 20 | 43% | $1.41M | N/A |
#9 | $1.1M | 6 | 20% | N/A | N/A |
#10 | $3.3M | 14 | 8% | N/A | N/A |
What Is Oxford Endovascular Ltd.?
Oxford Endovascular is a spin out from Oxford University developing technology to prevent brain haemorrhage.\n\nOxiFlow™️ is a novel, next generation flow-diverter, laser-cut from nitinol that diverts blood flow away from intracranial aneurysms at risk of rupture. Competitors have adverse events related to poor placement of devices due to their inherent design weaknesses. OxiFlow™️ is a unique design that places more accurately and safely than existing products, reducing risk of complications and conforms to blood vessel shapes making more patients treatable. Patented in Europe, US, China & Japan.\n\nCreated by world experts in the field, OxiFlow™ has gone through proof of concept pre-clinical studies that will be followed by a 1st in human study en-route to gaining FDA & CE mark.
keywords:N/AN/A
Total Funding
10
Number of Employees
$2.3M
Revenue (est)
-9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.6M | 10 | 0% | N/A |
#2 | $1.4M | 10 | -47% | $1M |
#3 | $2.1M | 10 | 0% | N/A |
#4 | $1M | 10 | 67% | N/A |
#5 | $3.5M | 11 | 10% | N/A |